386297-57-0

Basic information

• Product Name: 3'-[{2-[4-(aminosulfonyl)phenyl]ethyl}aminomethyl]-N-[2-(1-pyrrolidinyl)ethyl]-[1,1'-biphenyl]-3-carboxamide
• Synonyms: 3'-[{2-[4-(aminosulfonyl)phenyl]ethyl}aminomethyl]-N-[2-(1-pyrrolidinyl)ethyl]-[1,1'-biphenyl]-3-carboxamide
• CAS NO: 386297-57-0
• Molecular Weight: 506.669
• Mol File: 386297-57-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3'-[{2-[4-(aminosulfonyl)phenyl]ethyl}aminomethyl]-N-[2-(1-pyrrolidinyl)ethyl]-[1,1'-biphenyl]-3-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3'-[{2-[4-(aminosulfonyl)phenyl]ethyl}aminomethyl]-N-[2-(1-pyrrolidinyl)ethyl]-[1,1'-biphenyl]-3-carboxamide(386297-57-0)
• EPA Substance Registry System: 3'-[{2-[4-(aminosulfonyl)phenyl]ethyl}aminomethyl]-N-[2-(1-pyrrolidinyl)ethyl]-[1,1'-biphenyl]-3-carboxamide(386297-57-0)

Safety Data

• Hazardous Substances Data: 386297-57-0(Hazardous Substances Data)

Upstream product

• 386297-56-9 3'-formyl-N-[2-(1-pyrrolidinyl)ethyl][1,1'-biphenyl]-3-carboxamide 
• 112926-00-8 silica gel 
• 35303-76-5 4-(2-aminoethyl)benzenesulfonamide 

Relevant articles and documents

USE OF POLYPEPTIDE

The present invention provides uses of a polypeptide having a ligand activity to a sensory epithelium neuropeptide-like receptor (SENR) which is a G protein-coupled receptor protein, and a DNA encoding the same. More specifically, the present invention provides an anti-attention-deficit-disorder or anti-narcolepsy agent, which comprises a polypeptide having a ligand activity for SENR or a salt thereof, as well as a method for screening compounds having an anti-attention-deficit-disorder or anti-narcolepsy activity or compounds having an anti-anxiety, anti-depression, anti-insomnia, anti-schizophrenia or anti-fear activity or salts thereof, which comprises using the above polypeptide or a precursor protein of the polypeptide or a salt thereof.

Preventives and remedies for central nervous system diseases

A prophylactic or therapeutic agent for central nervous system diseases based on amyloid β40 secretion inhibitory activity of a compound having urotensin II receptor antagonistic activity or a salt thereof.